[go: up one dir, main page]

WO2012112410A3 - Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci - Google Patents

Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci Download PDF

Info

Publication number
WO2012112410A3
WO2012112410A3 PCT/US2012/024798 US2012024798W WO2012112410A3 WO 2012112410 A3 WO2012112410 A3 WO 2012112410A3 US 2012024798 W US2012024798 W US 2012024798W WO 2012112410 A3 WO2012112410 A3 WO 2012112410A3
Authority
WO
WIPO (PCT)
Prior art keywords
making
methods
same
placental tissue
micronized placental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/024798
Other languages
English (en)
Other versions
WO2012112410A2 (fr
Inventor
Brenda S. MORSE
Somaly SITH
Randall Spencer
Steven Ray
John Daniel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mimedx Group Inc
Original Assignee
Mimedx Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020197008298A priority Critical patent/KR102331661B1/ko
Priority to EP20171466.4A priority patent/EP3744336B1/fr
Priority to EP17190524.3A priority patent/EP3311826B1/fr
Priority to AU2012217975A priority patent/AU2012217975B2/en
Priority to KR1020137023726A priority patent/KR20140107103A/ko
Priority to JP2013553629A priority patent/JP6081378B2/ja
Priority to CA2826433A priority patent/CA2826433C/fr
Priority to KR1020247009039A priority patent/KR20240042159A/ko
Application filed by Mimedx Group Inc filed Critical Mimedx Group Inc
Priority to KR1020217038063A priority patent/KR102903446B1/ko
Priority to EP12746721.5A priority patent/EP2585084A4/fr
Publication of WO2012112410A2 publication Critical patent/WO2012112410A2/fr
Publication of WO2012112410A3 publication Critical patent/WO2012112410A3/fr
Priority to US13/787,612 priority patent/US10105397B2/en
Anticipated expiration legal-status Critical
Priority to US14/286,623 priority patent/US10105398B2/en
Priority to US14/286,638 priority patent/US10376546B2/en
Priority to AU2016200972A priority patent/AU2016200972B2/en
Priority to AU2017228658A priority patent/AU2017228658B2/en
Priority to US16/164,191 priority patent/US11219647B2/en
Priority to US16/164,274 priority patent/US11235007B2/en
Priority to US16/520,909 priority patent/US11103536B2/en
Priority to AU2019272042A priority patent/AU2019272042B2/en
Priority to US17/644,606 priority patent/US11931384B2/en
Priority to US17/647,505 priority patent/US20220125855A1/en
Priority to AU2022200614A priority patent/AU2022200614B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une composition constituée de composants placentaires micronisés et des compositions pharmaceutiques afférentes. Lesdites compositions possèdent de nombreuses applications médicales. L'invention porte également sur des méthodes de fabrication et d'utilisation desdites compositions micronisées.
PCT/US2012/024798 2011-02-14 2012-02-13 Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci Ceased WO2012112410A2 (fr)

Priority Applications (22)

Application Number Priority Date Filing Date Title
CA2826433A CA2826433C (fr) 2011-02-14 2012-02-13 Compositions micronisees de tissu placentaire, et methodes de fabrication et d'utilisation de celles-ci
EP17190524.3A EP3311826B1 (fr) 2011-02-14 2012-02-13 Compositions de tissus placentaux micronisés et leurs procédés de fabrication et d'utilisation
AU2012217975A AU2012217975B2 (en) 2011-02-14 2012-02-13 Micronized placental tissue compositions and methods for making and using the same
KR1020137023726A KR20140107103A (ko) 2011-02-14 2012-02-13 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
JP2013553629A JP6081378B2 (ja) 2011-02-14 2012-02-13 微粉化胎盤組織の組成物ならびにそれを作成および使用する方法
KR1020197008298A KR102331661B1 (ko) 2011-02-14 2012-02-13 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
EP12746721.5A EP2585084A4 (fr) 2011-02-14 2012-02-13 Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci
KR1020247009039A KR20240042159A (ko) 2011-02-14 2012-02-13 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
KR1020217038063A KR102903446B1 (ko) 2011-02-14 2012-02-13 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
EP20171466.4A EP3744336B1 (fr) 2011-02-14 2012-02-13 Compositions de tissus placentaux micronisés et leurs procédés de fabrication et d'utilisation
US13/787,612 US10105397B2 (en) 2011-02-14 2013-03-06 Micronized placental tissue compositions and methods of making and using the same
US14/286,623 US10105398B2 (en) 2011-02-14 2014-05-23 Micronized placental tissue compositions and methods of making and using the same
US14/286,638 US10376546B2 (en) 2011-02-14 2014-05-23 Micronized placental tissue compositions and methods of making and using the same
AU2016200972A AU2016200972B2 (en) 2011-02-14 2016-02-16 Micronized placental tissue compositions and methods for making and using the same
AU2017228658A AU2017228658B2 (en) 2011-02-14 2017-09-14 Micronized placental tissue compositions and methods for making and using the same
US16/164,191 US11219647B2 (en) 2011-02-14 2018-10-18 Micronized placental tissue compositions and methods of making and using the same
US16/164,274 US11235007B2 (en) 2011-02-14 2018-10-18 Micronized placental tissue compositions and methods of making and using the same
US16/520,909 US11103536B2 (en) 2011-02-14 2019-07-24 Micronized placental tissue compositions and methods of making and using the same
AU2019272042A AU2019272042B2 (en) 2011-02-14 2019-11-29 Micronized placental tissue compositions and methods of making and using the same
US17/644,606 US11931384B2 (en) 2011-02-14 2021-12-16 Micronized placental tissue compositions and methods of making and using the same
US17/647,505 US20220125855A1 (en) 2011-02-14 2022-01-10 Micronized placental tissue compositions and methods of making and using the same
AU2022200614A AU2022200614B2 (en) 2011-02-14 2022-01-31 Micronized placental tissue compositions and methods of making and using the same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161442348P 2011-02-14 2011-02-14
US61/442,348 2011-02-14
US201161543995P 2011-10-06 2011-10-06
US61/543,995 2011-10-06

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/787,612 Continuation US10105397B2 (en) 2011-02-14 2013-03-06 Micronized placental tissue compositions and methods of making and using the same

Publications (2)

Publication Number Publication Date
WO2012112410A2 WO2012112410A2 (fr) 2012-08-23
WO2012112410A3 true WO2012112410A3 (fr) 2013-01-24

Family

ID=46673099

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/024798 Ceased WO2012112410A2 (fr) 2011-02-14 2012-02-13 Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci

Country Status (2)

Country Link
AU (5) AU2012217975B2 (fr)
WO (1) WO2012112410A2 (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5906252B2 (ja) * 2010-12-20 2016-04-20 ステムニオン，インコーポレイテッド 歯科疾患、障害、および損傷の治療方法
AU2012217982B2 (en) 2011-02-14 2016-05-12 Mimedx Group Inc. Tissue grafts modified with a cross-linking agent and method of making and using the same
KR102903446B1 (ko) 2011-02-14 2025-12-24 미메딕스 그룹 인크. 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
WO2013082412A1 (fr) 2011-12-02 2013-06-06 Mimedx Group, Inc. Greffons de tissu placentaire produits par déshydratation chimique/ séchage par congélation et procédés de production et d'utilisation correspondants
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
CA2857636C (fr) 2011-12-22 2020-06-23 Mimedx Group Inc. Greffes de tissu placentaire deshydratees reticulees et procedes pour fabriquer et utiliser celles-ci
US11338063B2 (en) 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
EP2884944B1 (fr) 2012-08-15 2020-10-07 MiMedx Group, Inc. Greffes de tissu placentaire renforcées et procédés de fabrication et d'utilisation de celles-ci
US9180145B2 (en) 2012-10-12 2015-11-10 Mimedx Group, Inc. Compositions and methods for recruiting and localizing stem cells
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US9155799B2 (en) 2012-11-19 2015-10-13 Mimedx Group, Inc. Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
HK1218373A1 (zh) * 2012-12-27 2017-02-17 Lotus Tissue Repair Inc. 用於治療年齡相關失調的重組膠原蛋白7的給予
US10517931B2 (en) 2013-01-17 2019-12-31 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9827293B2 (en) 2013-01-17 2017-11-28 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9655948B1 (en) 2013-01-17 2017-05-23 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US10206977B1 (en) 2013-01-18 2019-02-19 Mimedx Group, Inc. Isolated placental stem cell recruiting factors
JP6545102B2 (ja) * 2013-01-18 2019-07-17 ミメディクス グループ インコーポレイテッド 心病態を治療する方法
CA2899246C (fr) 2013-03-13 2022-12-06 Allosource Compositions fibreuses de fascia et leurs procedes d'utilisation et de fabrication
WO2014149953A1 (fr) * 2013-03-15 2014-09-25 Cryolife, Inc. Procédés de préparation d'implants de tissu
US10029030B2 (en) * 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
WO2014150784A1 (fr) 2013-03-15 2014-09-25 Allosource Matrice de collagène repeuplée de cellules pour réparation et régénération des tissus mous
US10039792B1 (en) * 2013-03-16 2018-08-07 Brahm Holdings, Llc Methods for the treatment of inflammation and pain using human birth tissue material composition
EP3038630B1 (fr) 2013-08-30 2020-03-18 MIMEDX Group Inc. Compositions placentaires micronisées comprenant un chélateur
EP3043771A4 (fr) * 2013-09-10 2017-05-03 MIMEDX Group Inc. Utilisations cosmétiques de compositions placentaires moulées
KR102161901B1 (ko) 2013-12-06 2020-10-05 알로소스 조직의 시트를 건조하는 방법
WO2015109329A1 (fr) 2014-01-17 2015-07-23 Mimedx Group, Inc. Méthode pour induire l'angiogenèse
WO2015175776A1 (fr) * 2014-05-14 2015-11-19 NuTech Medical, Inc. Préparations de membrane placentaire, et leurs procédés de fabrication et d'utilisation pour régénérer un cartilage et des disques intervertébraux de la colonne vertébrale
US20150335686A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
TW201603818A (zh) * 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US20160008410A1 (en) 2014-07-08 2016-01-14 Mimedx Group, Inc. Micronized wharton's jelly
AU2015308795B2 (en) 2014-08-28 2019-05-23 Mimedx Group, Inc. Collagen reinforced tissue grafts
AU2015315228B2 (en) * 2014-09-09 2019-03-21 Mimedx Group, Inc. Micronized placental tissue compositions with optional sealant and methods of making and using the same
KR102683921B1 (ko) 2014-10-28 2024-07-11 바이오보텍 에이에스 미분화된 알껍데기 막 입자, 및 상처 치유를 촉진시키기 위한 이것의 용도
US10342830B2 (en) 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
US10736990B2 (en) 2015-02-11 2020-08-11 Mimedx Group, Inc. Collagen and micronized placental tissue compositions and methods of making and using the same
KR101701227B1 (ko) * 2015-02-12 2017-02-13 고려대학교 산학협력단 양막 및 융모막의 복합추출물을 유효성분으로 함유하는 골형성 촉진용 약학적 조성물
WO2016207355A1 (fr) 2015-06-24 2016-12-29 Biovotec As Échafaudages produits par ingénierie tissulaire comprenant de la membrane de coquille d'œuf sous forme particulaire
CN105018417B (zh) * 2015-07-22 2018-11-23 中国人民解放军第二军医大学 负载羊膜固有干细胞的冻存活性羊膜微粒及其条件培养基与应用
EP3349812B1 (fr) * 2015-09-17 2021-01-06 Stimlabs LLC Compositions dérivées de placenta et procédés pour les produire
EP3349813B1 (fr) * 2015-09-17 2021-09-01 Stimlabs LLC Compositions dérivées de placenta et procédés pour les produire
GB201519923D0 (en) 2015-11-11 2015-12-23 Biovotec Dac And Biovotec As Dry biocompatible disintegrateable films for delivering particulate egg shell membrane to a wound
US10993969B2 (en) 2016-02-05 2021-05-04 Gary M. Petrucci Methods and materials for treating nerve injuries and neurological disorders
AU2017316682B2 (en) 2016-08-24 2020-10-15 Arthrex, Inc. Tissue use for repair of injury
KR101824521B1 (ko) * 2016-12-26 2018-02-01 고려대학교 산학협력단 양막 및 융모막의 복합추출물을 유효성분으로 함유하는 골형성 촉진용 약학적 조성물
US10772986B2 (en) 2017-01-26 2020-09-15 Allosource Fascia fibrous compositions and methods for their use and manufacture
CN107349463A (zh) * 2017-06-16 2017-11-17 卓阮医疗科技（苏州）有限公司 一种生物源性止血微粒及其制备方法
US10478531B2 (en) * 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
US11154641B2 (en) 2017-12-22 2021-10-26 Stimlabs Llc Translucent, dehydrated placental tissue and methods of producing and using the same
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
AU2021324670A1 (en) * 2020-08-11 2023-02-02 Musculoskeletal Transplant Foundation Method for treating cardiac conditions with placenta-derived compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021762A1 (en) * 2005-07-13 2007-01-25 Qing Liu Ocular plug formed from placenta derived collagen biofabric
US20070299043A1 (en) * 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
US20080069895A1 (en) * 2006-08-15 2008-03-20 Qing Liu Umbilical cord biomaterial for medical use
WO2010029344A2 (fr) * 2008-09-10 2010-03-18 Burdica Biomed Limited Cryogel d’acide hyaluronique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0431164A4 (en) * 1989-04-21 1992-06-03 Kishinevsky Selskokhozyaistvenny Institut Imeni M.V. Frunze Preparation with an anti-inflammatory, lactogenous and stimulating action, and method of obtaining it
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
AU2003272536A1 (en) * 2002-09-18 2004-04-08 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
CA2736663C (fr) * 2007-09-07 2018-01-02 Surgical Biologics, Llc. Greffons de tissu placentaire et procedes ameliores pour leur preparation et leur utilisation
WO2012003377A2 (fr) * 2010-06-30 2012-01-05 Tissuetech, Inc. Procédé de préparation de tissu chorial et produits dérivés dudit tissu

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021762A1 (en) * 2005-07-13 2007-01-25 Qing Liu Ocular plug formed from placenta derived collagen biofabric
US20070299043A1 (en) * 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
US20080069895A1 (en) * 2006-08-15 2008-03-20 Qing Liu Umbilical cord biomaterial for medical use
WO2010029344A2 (fr) * 2008-09-10 2010-03-18 Burdica Biomed Limited Cryogel d’acide hyaluronique

Also Published As

Publication number Publication date
AU2019272042B2 (en) 2021-11-04
AU2017228658A1 (en) 2017-10-05
AU2019272042A1 (en) 2019-12-19
AU2022200614B2 (en) 2025-01-30
WO2012112410A2 (fr) 2012-08-23
AU2016200972A1 (en) 2016-03-03
AU2012217975B2 (en) 2015-11-19
AU2016200972B2 (en) 2017-06-15
AU2022200614A1 (en) 2022-02-24
AU2017228658B2 (en) 2019-08-29
AU2012217975A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
WO2012112410A3 (fr) Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci
WO2014058804A3 (fr) Compositions micronisées composées de greffons osseux et leurs procédés de fabrication et d'utilisation
EP2585084A4 (fr) Compositions micronisées de tissu placentaire, et méthodes de fabrication et d'utilisation de celles-ci
WO2012065022A3 (fr) Spiro-oxindoles antagonistes de mdm2
WO2012024620A3 (fr) Inhibiteurs de l'autotaxine et leurs utilisations
WO2011060049A3 (fr) Antagonistes, de type spiro-oxindole, de l'oncoprotéine mdm2
EP2884844A4 (fr) Compositions micronisées de tissu placentaire et méthodes de fabrication et d'utilisation associées
WO2012030993A3 (fr) Compositions pour la peau et leurs applications
WO2011086093A3 (fr) Compositions pharmaceutiques pour l'administration orale de peptides de l'insuline
WO2012055567A3 (fr) Utilisation de malononitrilamides dans la douleur neuropathique
WO2012047856A3 (fr) Nouveaux inhibiteurs de la sécrétion d'antigènes du virus de l'hépatite b
WO2014039903A3 (fr) Formulations aqueuses stables d'adalimumab
WO2012021715A3 (fr) Formulations stables de linaclotide
WO2012155066A3 (fr) Agonistes de mdm2 consistant en spiro-oxindoles
EP4414376A3 (fr) Nouveau depsipeptide et ses utilisations
BR112014021531A8 (pt) composto, composição farmacêutica e usos dos mesmos
IL224288A (en) Derivatives of converted pyrazolamide, pharmaceutical preparations containing them and their use
WO2012154679A8 (fr) Composés de sulfonamide pyrazole tricycliques et leurs procédés de fabrication et d'utilisation
WO2012051318A8 (fr) Composés sulfonamides et leurs procédés de fabrication et d'utilisation
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
WO2012047587A3 (fr) Inhibiteurs de mdm2 pour le traitement d'affections oculaires
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
HK1206028A1 (en) Phenicol antibacterials
PL2768936T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
WO2011150201A3 (fr) Composés azolylamide et leurs procédés d'utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12746721

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2012746721

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012746721

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2826433

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2013553629

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20137023726

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2012217975

Country of ref document: AU

Date of ref document: 20120213

Kind code of ref document: A

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)